BUY Biocon Ltd — DAM Capital
byDAM CapitalHorizon: NA (inferred 1 year)15 Jul 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·7 Sept · yesterday
Biocon Biologics Secures Japan Approval for Pegfilgrastim Biosimilar
NewsGoogle News·25 Aug · 2w ago
Biocon arm gets Japan nod for cancer drug pegfilgrastim biosimilar
NewsGoogle News·25 Aug · 2w ago
Vikas Khemani bets big on India's manufacturing shift, sees Biocon at an "inflection point"
NewsCnbc-Tv18·21 Aug · 2w ago
Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector
NewsEt-Markets·18 Aug · 3w ago
Buy, Sell Or Hold: IndiGo, Maruti Suzuki, Biocon, LIC, Hindustan Copper, Bharat Dynamics — Ask Profit
NewsNdtv-Profit·2 Sept · 5d ago
Buy, Sell Or Hold: Mahindra & Mahindra, Coforge, TVS Motor, Biocon And Divi's Labs — Ask Profit
NewsNdtv-Profit·30 Aug · 1w ago
Buy, Sell Or Hold: Mazagon Dock, HAL, Biocon, Suzlon And Tata Motors PV — Ask Profit
NewsNdtv-Profit·18 Aug · 3w ago
Biocon shares fall 2.06% in early trade
NewsGoogle News·13 Aug · 4w ago
3 other SEBI-registered advisors have active long-term SELL calls on this stock
Advisor consensus · same horizon·15 Jul · 2mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.